ArticleAntiviral research2019

Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV.

Shalley N Kudalkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.